» Articles » PMID: 35587980

Universal Antigen Encoding of T Cell Activation from High-dimensional Cytokine Dynamics

Overview
Journal Science
Specialty Science
Date 2022 May 19
PMID 35587980
Authors
Affiliations
Soon will be listed here.
Abstract

Systems immunology lacks a framework with which to derive theoretical understanding from high-dimensional datasets. We combined a robotic platform with machine learning to experimentally measure and theoretically model CD8 T cell activation. High-dimensional cytokine dynamics could be compressed onto a low-dimensional latent space in an antigen-specific manner (so-called "antigen encoding"). We used antigen encoding to model and reconstruct patterns of T cell immune activation. The model delineated six classes of antigens eliciting distinct T cell responses. We generalized antigen encoding to multiple immune settings, including drug perturbations and activation of chimeric antigen receptor T cells. Such universal antigen encoding for T cell activation may enable further modeling of immune responses and their rational manipulation to optimize immunotherapies.

Citing Articles

Modeling the response to interleukin-21 to inform natural killer cell immunotherapy.

Nayak I, Biondo R, Stewart W, Fulton R, Moker N, Zhang C Immunol Cell Biol. 2025; 103(2):192-212.

PMID: 39865344 PMC: 11792776. DOI: 10.1111/imcb.12848.


Should Artificial Intelligence Play a Durable Role in Biomedical Research and Practice?.

Bongrand P Int J Mol Sci. 2025; 25(24.

PMID: 39769135 PMC: 11676049. DOI: 10.3390/ijms252413371.


Cytokine-overexpressing dendritic cells for cancer immunotherapy.

Han J, Wang H Exp Mol Med. 2024; 56(12):2559-2568.

PMID: 39617785 PMC: 11671598. DOI: 10.1038/s12276-024-01353-5.


Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia.

Cao H, Xiao J, Baylink D, Nguyen V, Shim N, Lee J Biomedicines. 2024; 12(10).

PMID: 39457563 PMC: 11504511. DOI: 10.3390/biomedicines12102250.


Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach.

Bar O, Porgador A, Cooks T J Extracell Biol. 2024; 3(9):e70011.

PMID: 39328262 PMC: 11424882. DOI: 10.1002/jex2.70011.